These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 17270372)

  • 1. Role of copper gluconate/triethanolamine in irinotecan encapsulation inside the liposomes.
    Dicko A; Tardi P; Xie X; Mayer L
    Int J Pharm; 2007 Jun; 337(1-2):219-28. PubMed ID: 17270372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intra and inter-molecular interactions dictate the aggregation state of irinotecan co-encapsulated with floxuridine inside liposomes.
    Dicko A; Frazier AA; Liboiron BD; Hinderliter A; Ellena JF; Xie X; Cho C; Weber T; Tardi PG; Cabral-Lilly D; Cafiso DS; Mayer LD
    Pharm Res; 2008 Jul; 25(7):1702-13. PubMed ID: 18320294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coencapsulation of irinotecan and floxuridine into low cholesterol-containing liposomes that coordinate drug release in vivo.
    Tardi PG; Gallagher RC; Johnstone S; Harasym N; Webb M; Bally MB; Mayer LD
    Biochim Biophys Acta; 2007 Mar; 1768(3):678-87. PubMed ID: 17208196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Copper ion-mediated liposomal encapsulation of mitoxantrone: the role of anions in drug loading, retention and release.
    Li C; Cui J; Li Y; Wang C; Li Y; Zhang L; Zhang L; Guo W; Wang J; Zhang H; Hao Y; Wang Y
    Eur J Pharm Sci; 2008 Aug; 34(4-5):333-44. PubMed ID: 18573336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel liposomal irinotecan formulation with significant anti-tumour activity: use of the divalent cation ionophore A23187 and copper-containing liposomes to improve drug retention.
    Ramsay E; Alnajim J; Anantha M; Zastre J; Yan H; Webb M; Waterhouse D; Bally M
    Eur J Pharm Biopharm; 2008 Mar; 68(3):607-17. PubMed ID: 17904831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transition metal-mediated liposomal encapsulation of irinotecan (CPT-11) stabilizes the drug in the therapeutically active lactone conformation.
    Ramsay E; Alnajim J; Anantha M; Taggar A; Thomas A; Edwards K; Karlsson G; Webb M; Bally M
    Pharm Res; 2006 Dec; 23(12):2799-808. PubMed ID: 17063397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the transition metal copper and the ionophore A23187 in the development of Irinophore C™.
    Patankar N; Anantha M; Ramsay E; Waterhouse D; Bally M
    Pharm Res; 2011 Apr; 28(4):848-57. PubMed ID: 21181548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of intraliposomal pH and its effect on membrane partitioning and passive loading of a hydrophobic camptothecin, DB-67.
    Joguparthi V; Feng S; Anderson BD
    Int J Pharm; 2008 Mar; 352(1-2):17-28. PubMed ID: 18065174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biophysical characterization of a liposomal formulation of cytarabine and daunorubicin.
    Dicko A; Kwak S; Frazier AA; Mayer LD; Liboiron BD
    Int J Pharm; 2010 May; 391(1-2):248-59. PubMed ID: 20156541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation and comparative characterization of chitosan, gelatin, and chitosan-gelatin-coated liposomes of CPT-11-HCl.
    Shende P; Gaud R
    Drug Dev Ind Pharm; 2009 May; 35(5):612-8. PubMed ID: 18951273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Irinotecan binds to the internal cavity of beta-lactoglobulin: A multi-spectroscopic and computational investigation.
    Bijari N; Ghobadi S; Derakhshandeh K
    J Pharm Biomed Anal; 2017 May; 139():109-115. PubMed ID: 28279925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Keratin films from chicken feathers for controlled drug release.
    Li FY; Wang RM; He YF; Li XX; Song PF; Ying XC; Mao CW
    J Control Release; 2011 Nov; 152 Suppl 1():e92-3. PubMed ID: 22195951
    [No Abstract]   [Full Text] [Related]  

  • 13. Preparation, characterization and biodistribution of the lactone form of 10-hydroxycamptothecin (HCPT)-loaded bovine serum albumin (BSA) nanoparticles.
    Yang L; Cui F; Cun D; Tao A; Shi K; Lin W
    Int J Pharm; 2007 Aug; 340(1-2):163-72. PubMed ID: 17482779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and cytotoxicity studies of DPPC:M(2+) novel delivery system for cisplatin thermosensitivity liposome with improving loading efficiency.
    Liu H; Zhang Y; Han Y; Zhao S; Wang L; Zhang Z; Wang J; Cheng J
    Colloids Surf B Biointerfaces; 2015 Jul; 131():12-20. PubMed ID: 25938850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hexosomes formed from glycerate surfactants--formulation as a colloidal carrier for irinotecan.
    Boyd BJ; Whittaker DV; Khoo SM; Davey G
    Int J Pharm; 2006 Aug; 318(1-2):154-62. PubMed ID: 16621358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, characterization and in vitro release studies of a new acetazolamide-HP-beta-CD-TEA inclusion complex.
    Granero GE; Maitre MM; Garnero C; Longhi MR
    Eur J Med Chem; 2008 Mar; 43(3):464-70. PubMed ID: 17544174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced active liposomal loading of a poorly soluble ionizable drug using supersaturated drug solutions.
    Modi S; Xiang TX; Anderson BD
    J Control Release; 2012 Sep; 162(2):330-9. PubMed ID: 22800581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug carriers based on cyclodextrin inclusion complexes for the controlled release of hydrophobic drugs.
    Xiong L; Zheng L; Han K; Liu Q; Li Y; Liu W; Xia J; Wang W
    J Control Release; 2011 Nov; 152 Suppl 1():e121-3. PubMed ID: 22195793
    [No Abstract]   [Full Text] [Related]  

  • 19. Encapsulation of Isoniazid-conjugated Phthalocyanine-In-Cyclodextrin-In-Liposomes Using Heating Method.
    Nkanga CI; Krause RWM
    Sci Rep; 2019 Aug; 9(1):11485. PubMed ID: 31391517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sphingomyelin Liposomes Containing Porphyrin-phospholipid for Irinotecan Chemophototherapy.
    Carter KA; Luo D; Razi A; Geng J; Shao S; Ortega J; Lovell JF
    Theranostics; 2016; 6(13):2329-2336. PubMed ID: 27877238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.